Objective To determine the effectiveness and safety of moderate whole-body hypothermia in
newborns with hypoxic-ischemic encephalopathy born in hospitals with and without …

Importance Hypothermia for 72 hours at 33.5° C for neonatal hypoxic-ischemic
encephalopathy reduces death or disability, but rates continue to be high. Objective To …

OBJECTIVE: To investigate the efficacy and safety of selective head cooling with mild
systemic hypothermia in hypoxic-ischemic encephalopathy (HIE) in newborn infants. STUDY …

Hypoxic-ischemic encephalopathy (HIE) is the most common cause of neonatal
encephalopathy with a global incidence of approximately 1 to 8 per 1,000 live births …

OBJECTIVE: To examine the predictive ability of stage of hypoxic-ischemic encephalopathy
(HIE) for death or moderate/severe disability at 18 months among neonates undergoing …

Background Neonatal hypoxic-ischemic encephalopathy (HIE) affects as many as 100,000
infants each year in China. Therapeutic hypothermia reduces HIE related mortality and long …

Background Moderate hypothermia in neonates with hypoxic–ischaemic encephalopathy
might improve survival and neurological outcomes at up to 18 months of age, although …

Objective: Therapeutic hypothermia instituted within 6 h of birth has been shown to improve
neurodevelopmental outcomes in term newborns with moderate–to–severe hypoxic …

Objective Hypoxic-ischaemic encephalopathy (HIE) remains a leading cause of neonatal
mortality and neurodisability. We aimed to determine the incidence of HIE and management …

Background and Objective: There remains an unmet clinical need for markers that predict
outcomes in the hypothermia-treated (HT) infants with HIE. The aim of this meta-analysis …